Come join others currently navigating treatment in our weekly Zoom Meetup! Register here: Tuesdays, 1pm ET.
Take our poll: How does Breast Cancer Awareness Month make you feel?
Treatment After CDK4/6 Inhibitors
moderators
Posts: 8,503
Treatment After CDK4/6 Inhibitors
Dec 5, 2023
Medical oncologist Stephanie Graff explains the treatment options available after a CDK4/6 inhibitor stops working.
CDK4/6 inhibitors are used to treat both early-stage and advanced-stage hormone receptor-positive, HER2-negative breast cancer.
The CDK4/6 inhibitors are:
- Ibrance (chemical name: palbociclib)
- Kisqali (chemical name: ribociclib)
- Verzenio (chemical name: abemaciclib)
At the 2023 San Antonio Breast Cancer Symposium, Dr. Stephanie Graff moderated an educational session to help people and their doctors decide on treatments after a CDK4/6 inhibitor has stopped working.
Listen to the podcast to hear Dr. Graff explain:
Tagged:
0
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.